Navigation Links
Blue Cross Blue Shield of North Carolina Implements Aggressive Generic Medication Campaign
Date:4/16/2008

The Plan Moves More than 40 Tier 3 Drugs for Chronic Diseases to Tier 2,

According to a New Report from HealthLeaders-InterStudy

NASHVILLE, Tenn., April 16 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that Blue Cross and Blue Shield of North Carolina has begun an aggressive generic medication campaign as of January 2008 in which it waives the copayment on all generic drugs that treat congestive heart failure, high blood pressure, high cholesterol and diabetes. According to the new report entitled Blue Profiler: Blue Cross and Blue Shield of North Carolina, the campaign, called Medication Dedication, is the plan's attempt to encourage members to take prescription drugs as directed and to make the overall cost of drugs more affordable.

"In 2007, Blue Cross and Blue Shield of North Carolina's generic utilization rate was higher than its two major competitors, UnitedHealthcare and CIGNA Healthcare," said Heather Wicks, analyst at HealthLeaders- InterStudy. "The Blue Plan's rate was 58 percent in 2007, up from 46.8 percent in 2004."

The report also finds that Blue Cross and Blue Shield of North Carolina has moved more than 40 drugs to treat chronic diseases from Tier 3 to Tier 2 as part of its Medication Dedication program. For example, Tier 3 drugs to treat diabetes moved to Tier 2 status include Byetta, Fortamet, Glucagen, Glumetza, Glyset, Prandin, Riomet, Starlit and Symlin.

"Blue Cross Blue Shield of North Carolina had been more aggressive than competitors CIGNA Healthcare and UnitedHealthcare in the placement of more expensive brand-name drugs in tiers requiring higher copays," continued Ms. Wicks. "However, the decision to move more drugs to lower tiers in 2008 should put Blue Cross Blue Shield of North Carolina more in line with other payers."

Blue Profiler: Blue Cross and Blue Shield of North Carolina is one of 15 2008 Blue Profiler reports on the nation's largest nonprofit Blue Cross Blue Shield plans, which together insure more than 50 million people.

About Blue Profiler

Blue Profiler offers the most comprehensive analysis of the nonprofit Blue Cross Blue Shield plans. Each report includes an individual nonprofit Blue plan and includes valuable analysis that will allow companies to more effectively partner with these dominant organizations. Each report includes information on:

-- Competitive analysis

-- Enrollment trends

-- Company-wide financials

-- HMO financials

-- Consumer-driven products

-- Medicare strategy

-- Pharmacy

-- Disease Management

About HealthLeaders-InterStudy

HealthLeaders-InterStudy (http://www.hl-isy.com) is the authoritative source for managed care data and analysis. HealthLeaders-InterStudy is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Using HR Performance Metrics to Drive Costs Down Across HR Functions
2. Cedar Point to Host 17th Annual Red Cross Miniature Golf Event
3. Two Men to Walk Across America for Autism Aid, Awareness, and Loving Memory of Young Boy
4. Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk
5. Kids With Cell Phones Not as Safe Crossing Streets
6. Blue Cross and Blue Shield of Oklahoma Launches an Integrated Medical-Dental Health Program
7. Anthem Blue Cross Tackles Childhood Obesity in California Through Free BMI Workshops for Pediatric and Family Medicine Health Care Providers
8. Business Leader, Nonprofit Volunteer to Head the American Red Cross
9. Researchers Able to Continue their Work to Help Patients Thanks to McDevitt Excellence in Research Awards from Blue Cross Blue Shield of Michigan Foundation
10. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
11. Partnership for Prescription Assistance Celebrates Three Year Anniversary; Helps Nearly 5 Million Uninsured Patients Across United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology: